MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY-Reference-Cited by-同舟云学术

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

Published:2000-04 Issue:4 Volume:163 Page:1124-1129
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

LAMM DONALD L.¹,BLUMENSTEIN BRENT A.¹,CRISSMAN JOHN D.¹,MONTIE JAMES E.¹,GOTTESMAN JAMES E.¹,LOWE BRUCE A.¹,SAROSDY MICHAEL F.¹,BOHL ROBERT D.¹,GROSSMAN H. BARTON¹,BECK THOMAS M.¹,LEIMERT JOSEPH T.¹,CRAWFORD E. DAVID¹

Affiliation:

1. From the West Virginia University Medical Center, Morgantown, West Virginia, Southwest Oncology Group Statistical Center and Swedish Hospital Tumor Institute, Seattle, Washington, Harper Hospital, Detroit and University of Michigan Medical Center, Ann Arbor, Michigan, Oregon Health Sciences University and Northwest Clinical Oncology Program, Portland, Oregon, University of Texas Health Science Center at San Antonio, San Antonio and University of Texas M. D. Anderson Cancer Center, Houston, Texas,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference33 articles.

1. Bacillus Calmette-Guerin therapy alters the progression of superficial bladder cancer;Herr;J Clin Oncol,1988

2. Long-term results of intravesical therapy for superficial bladder cancer;Lamm;Urol Clin North Am,1992

3. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer;Pawinski;J. Urol,1996

4. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder;Lamm;N Engl J Med,1991

5. Randomized intergroup comparison of bacillus Calmette-Guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder: a Southwest Oncology Group study;Lamm;Urol Oncol,1995

Cited by 1062 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Bacillus Calmette–Guerin Exposure on Prostate Cancer Detection Using Magnetic Resonance Imaging: A Cohort Study;Clinical Genitourinary Cancer;2024-10

2. Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2024-09

3. Neue Therapieansätze beim nicht-muskelinvasiven Urothelkarzinom der Harnblase – Ist der Organerhalt auch nach BCG (Bacillus Calmette-Guérin) möglich?;Die Urologie;2024-08-23

4. Revitalizing Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches;Pharmaceutics;2024-08-15

5. Toxoplasma gondii infection supports the infiltration of T cells into brain tumors;Journal of Neuroimmunology;2024-08